rs748531024

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_004928.3(CFAP410):​c.33_34insAGCTGCACAGCGTGCA​(p.Ala12SerfsTer60) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00008 in 1,474,772 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R11R) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000080 ( 0 hom. )

Consequence

CFAP410
NM_004928.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:9

Conservation

PhyloP100: 0.0680

Publications

1 publications found
Variant links:
Genes affected
CFAP410 (HGNC:1260): (cilia and flagella associated protein 410) Four alternatively spliced transcript variants encoding four different isoforms have been found for this nuclear gene. All isoforms contain leucine-rich repeats. Three of these isoforms are mitochondrial proteins and one of them lacks the target peptide, so is not located in mitochondrion. This gene is down-regulated in Down syndrome (DS) brain, which may represent mitochondrial dysfunction in DS patients. [provided by RefSeq, Sep 2012]
CFAP410 Gene-Disease associations (from GenCC):
  • axial spondylometaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 34 pathogenic variants in the truncated region.
PP5
Variant 21-44339161-C-CTGCACGCTGTGCAGCT is Pathogenic according to our data. Variant chr21-44339161-C-CTGCACGCTGTGCAGCT is described in ClinVar as Pathogenic. ClinVar VariationId is 438159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFAP410NM_004928.3 linkc.33_34insAGCTGCACAGCGTGCA p.Ala12SerfsTer60 frameshift_variant Exon 1 of 7 ENST00000339818.9 NP_004919.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFAP410ENST00000339818.9 linkc.33_34insAGCTGCACAGCGTGCA p.Ala12SerfsTer60 frameshift_variant Exon 1 of 7 1 NM_004928.3 ENSP00000344566.4 O43822-1
CFAP410ENST00000397956.7 linkc.33_34insAGCTGCACAGCGTGCA p.Ala12SerfsTer60 frameshift_variant Exon 1 of 7 1 ENSP00000381047.3 O43822-4
CFAP410ENST00000325223.7 linkc.33_34insAGCTGCACAGCGTGCA p.Ala12SerfsTer60 frameshift_variant Exon 1 of 7 1 ENSP00000317302.7 O43822-3
ENSG00000232969ENST00000426029.1 linkn.-215_-214insTGCACGCTGTGCAGCT upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0000790
AC:
12
AN:
151840
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000133
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000436
AC:
4
AN:
91818
AF XY:
0.0000388
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000137
Gnomad NFE exome
AF:
0.0000633
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000801
AC:
106
AN:
1322932
Hom.:
0
Cov.:
32
AF XY:
0.0000736
AC XY:
48
AN XY:
652506
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26754
American (AMR)
AF:
0.00
AC:
0
AN:
25286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23162
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28014
South Asian (SAS)
AF:
0.00
AC:
0
AN:
71630
European-Finnish (FIN)
AF:
0.000171
AC:
8
AN:
46804
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5352
European-Non Finnish (NFE)
AF:
0.0000931
AC:
97
AN:
1041712
Other (OTH)
AF:
0.0000184
AC:
1
AN:
54218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.403
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000790
AC:
12
AN:
151840
Hom.:
0
Cov.:
31
AF XY:
0.0000674
AC XY:
5
AN XY:
74176
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41364
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.000133
AC:
9
AN:
67888
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000216
Hom.:
0
Bravo
AF:
0.0000491

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CFAP410: PVS1, PM2 -

Jan 20, 2020
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed with a second pathogenic variant in a patient with retinitis pigmentosa in published literature (Carss et al., 2017), although the phase of these two variants was not confirmed; This variant is associated with the following publications: (PMID: 32581362, 28041643) -

Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Ala12Serfs*60) in the CFAP410 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFAP410 are known to be pathogenic (PMID: 23105016, 26167768). This variant is present in population databases (rs748531024, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with retinal dystrophy (PMID: 28041643). ClinVar contains an entry for this variant (Variation ID: 438159). For these reasons, this variant has been classified as Pathogenic. -

Retinal dystrophy Pathogenic:3
Jan 01, 2020
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 01, 2015
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Aug 09, 2019
Blueprint Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa Pathogenic:2
Jan 01, 2015
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Jul 24, 2023
Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

Clinical significance based on ACMG v2.0 -

CFAP410-related disorder Pathogenic:1
Sep 09, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The CFAP410 c.33_34insAGCTGCACAGCGTGCA variant is predicted to result in a frameshift and premature protein termination (p.Ala12Serfs*60). This variant has been reported in individuals with retinitis pigmentosa (see for examples: Carss et al. 2016. PubMed ID: 28041643; Areblom et al. 2023. PubMed ID: 37510321; Table S1, Lin et al. 2024. PubMed ID: 38219857). This variant is reported in 0.017% of alleles in individuals of European (Finnish) descent in gnomAD. Frameshift variants in CFAP410 are an established mechanism of disease. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.068
Mutation Taster
=9/191
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748531024; hg19: chr21-45759044; API